Biomedical literature, made navigable
Discover articles through diseases, drugs, treatments, interventions, clinical instruments, institutions and funders extracted from the BMJ open corpus.
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsChoose an entity to see the articles in which it was identified.
…without portal hypertension or synthetic failure), and stage 3 (cirrhosis with portal hypertension but without decompensation). Late-stag…
…Objectives Non-insertional Achilles tendinopathy (AT) is a common running injury. Exercise loading programme (EX…
… of nivolumab SC 720 mg or 960 mg±rHuPH20 2000 U/mL followed by nivolumab intravenous (IV) 480 mg every 4 weeks (Q4W). Patients receiving…
… rates were compared between groups.Results Of 33 patients with SLE-TTP, 31 (94%) achieved clinical remission following RTX-containing …
…tment rationale (OLP–), or OLP with treatment rationale (OLP+). OLP consisted of two placebo pills per day for 6 weeks.Main outcome…
…sone (8 mg) before induction and surgical incision, followed by ketamine (0.2 mg/kg/h) and remifentanil (TCI 1 ng/mL) infusions. In the …
… duration of the analgesia was 636.4±212.4 minutes (mean±SD) in bupivacaine group when compared to 715.9±261.6 minutes in ropivacaine group…
…, Pope J, Hayek S, et al. Neurostimulation for the treatment of axial back pain: a review of mechanisms, techniques, outcomes, and future advan…
… the Oncology inpatient service who had metastatic cancer or on palliative cancer treatment. Patients in collusion, lacking mental capacity or critically i…
…ent followed by another anti-TNFa treatment or Vedolizumab then Ustekinumab. Median age at diagnosis was 8 years. We found that (40%) switc…
…ents with moderate to severe pruritus undergoing haemodialysis, anrikefon was found to be safe and resulted in a noticeable reduction in …
…ts of viloxazine on sleep quality appeared partly attenuated by trazodone.Trial registration number NCT05793684.…